Docusign (NASDAQ:DOCU) Given New $69.00 Price Target at Morgan Stanley

Docusign (NASDAQ:DOCU) had its target price lowered by Morgan Stanley from $90.00 to $69.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

A number of other research firms also recently weighed in on DOCU. Robert W. Baird decreased their price target on shares of Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research note on Wednesday. JPMorgan Chase & Co. cut their price objective on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Bank of America reduced their target price on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Docusign in a research note on Wednesday, January 21st. Finally, Royal Bank Of Canada reduced their price objective on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research note on Wednesday. Five analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to MarketBeat.com, Docusign currently has an average rating of “Hold” and a consensus target price of $66.67.

Docusign Price Performance

Shares of Docusign stock opened at $48.90 on Wednesday. The firm has a market cap of $9.79 billion, a price-to-earnings ratio of 33.04, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The stock’s 50-day moving average is $50.69 and its 200-day moving average is $64.35. Docusign has a one year low of $40.16 and a one year high of $94.67.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.70% and a net margin of 9.60%.The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same period last year, the company earned $0.86 earnings per share. Docusign’s quarterly revenue was up 7.8% on a year-over-year basis. On average, equities analysts expect that Docusign will post 1.17 EPS for the current year.

Docusign declared that its board has authorized a stock buyback plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

Insider Activity at Docusign

In other Docusign news, insider James P. Shaughnessy sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the completion of the sale, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. This trade represents a 18.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 6,500 shares of the company’s stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $70.00, for a total value of $455,000.00. Following the completion of the transaction, the chief financial officer directly owned 111,713 shares in the company, valued at $7,819,910. The trade was a 5.50% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 51,477 shares of company stock valued at $3,521,607. 1.01% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Central Pacific Bank Trust Division bought a new position in Docusign during the 4th quarter worth $25,000. Modus Advisors LLC bought a new stake in shares of Docusign in the fourth quarter valued at about $27,000. Torren Management LLC acquired a new position in shares of Docusign in the fourth quarter valued at about $28,000. True Wealth Design LLC grew its stake in shares of Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC bought a new position in Docusign during the fourth quarter worth about $30,000. 77.64% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.